These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 30702751)

  • 41. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
    Lue LF; Walker DG
    J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicroglia antibodies in sera of Alzheimer's disease patients.
    Lemke MR; Glatzel M; Henneberg AE
    Biol Psychiatry; 1999 Feb; 45(4):508-11. PubMed ID: 10071725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome.
    Tejera D; Mercan D; Sanchez-Caro JM; Hanan M; Greenberg D; Soreq H; Latz E; Golenbock D; Heneka MT
    EMBO J; 2019 Sep; 38(17):e101064. PubMed ID: 31359456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microglial activation occurs late during preclinical Alzheimer's disease.
    Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I
    Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microglia in Alzheimer's disease: A multifaceted relationship.
    ElAli A; Rivest S
    Brain Behav Immun; 2016 Jul; 55():138-150. PubMed ID: 26254232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased expression of the urokinase plasminogen-activator receptor in amyloid beta peptide-treated human brain microglia and in AD brains.
    Walker DG; Lue LF; Beach TG
    Brain Res; 2002 Feb; 926(1-2):69-79. PubMed ID: 11814408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microglial activation in Alzheimer's disease.
    Schlachetzki JC; Hüll M
    Curr Alzheimer Res; 2009 Dec; 6(6):554-63. PubMed ID: 19747160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: a putative marker of an ongoing inflammatory process.
    McRae A; Martins RN; Fonte J; Kraftsik R; Hirt L; Miklossy J
    Exp Gerontol; 2007 Apr; 42(4):355-63. PubMed ID: 17140756
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alzheimer's Disease Research Using Human Microglia.
    Lue LF; Beach TG; Walker DG
    Cells; 2019 Aug; 8(8):. PubMed ID: 31387311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The evolving biology of microglia in Alzheimer's disease.
    Malm TM; Jay TR; Landreth GE
    Neurotherapeutics; 2015 Jan; 12(1):81-93. PubMed ID: 25404051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microglia as a potential bridge between the amyloid beta-peptide and tau.
    Kitazawa M; Yamasaki TR; LaFerla FM
    Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model.
    Guedes JR; Custódia CM; Silva RJ; de Almeida LP; Pedroso de Lima MC; Cardoso AL
    Hum Mol Genet; 2014 Dec; 23(23):6286-301. PubMed ID: 24990149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.
    Ardestani PM; Evans AK; Yi B; Nguyen T; Coutellier L; Shamloo M
    Neuropharmacology; 2017 Apr; 116():371-386. PubMed ID: 28089846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Developmental toxicant exposure in a mouse model of Alzheimer's disease induces differential sex-associated microglial activation and increased susceptibility to amyloid accumulation.
    vonderEmbse AN; Hu Q; DeWitt JC
    J Dev Orig Health Dis; 2017 Aug; 8(4):493-501. PubMed ID: 28460650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review.
    Park JC; Han SH; Mook-Jung I
    BMB Rep; 2020 Jan; 53(1):10-19. PubMed ID: 31865964
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microglial Function and Regulation during Development, Homeostasis and Alzheimer's Disease.
    Casali BT; Reed-Geaghan EG
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microglial pathology in Down syndrome.
    Xue QS; Streit WJ
    Acta Neuropathol; 2011 Oct; 122(4):455-66. PubMed ID: 21847625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of the peripheral innate immune system in the development of Alzheimer's disease.
    Le Page A; Dupuis G; Frost EH; Larbi A; Pawelec G; Witkowski JM; Fulop T
    Exp Gerontol; 2018 Jul; 107():59-66. PubMed ID: 29275160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beclin1-driven autophagy modulates the inflammatory response of microglia via NLRP3.
    Houtman J; Freitag K; Gimber N; Schmoranzer J; Heppner FL; Jendrach M
    EMBO J; 2019 Feb; 38(4):. PubMed ID: 30617086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.